Imágenes en Dermatología
Utilidad de la azitromicina en la hiperplasia gingival inducida por ciclosporina
Azithromycin for the Treatment of Ciclosporin-Induced Gingival Hyperplasia
Leído
7223
Vecesse ha leído el artículo
2089
Total PDF
5134
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 4 | 20 |
| 2025 5 | 139 | 24 | 163 |
| 2025 4 | 106 | 24 | 130 |
| 2025 3 | 109 | 21 | 130 |
| 2025 2 | 117 | 37 | 154 |
| 2025 1 | 87 | 23 | 110 |
| 2024 12 | 76 | 26 | 102 |
| 2024 11 | 78 | 69 | 147 |
| 2024 10 | 70 | 47 | 117 |
| 2024 9 | 80 | 26 | 106 |
| 2024 8 | 90 | 54 | 144 |
| 2024 7 | 98 | 30 | 128 |
| 2024 6 | 115 | 28 | 143 |
| 2024 5 | 91 | 35 | 126 |
| 2024 4 | 82 | 26 | 108 |
| 2024 3 | 72 | 34 | 106 |
| 2024 2 | 66 | 35 | 101 |
| 2024 1 | 54 | 27 | 81 |
| 2023 12 | 83 | 23 | 106 |
| 2023 11 | 93 | 21 | 114 |
| 2023 10 | 81 | 14 | 95 |
| 2023 9 | 84 | 27 | 111 |
| 2023 8 | 50 | 15 | 65 |
| 2023 7 | 77 | 26 | 103 |
| 2023 6 | 64 | 20 | 84 |
| 2023 5 | 103 | 27 | 130 |
| 2023 4 | 69 | 18 | 87 |
| 2023 3 | 63 | 21 | 84 |
| 2023 2 | 61 | 22 | 83 |
| 2022 1 | 67 | 22 | 89 |
| 2022 12 | 67 | 31 | 98 |
| 2022 11 | 91 | 30 | 121 |
| 2022 10 | 77 | 35 | 112 |
| 2022 9 | 58 | 55 | 113 |
| 2022 8 | 104 | 53 | 157 |
| 2022 7 | 102 | 51 | 153 |
| 2022 6 | 90 | 29 | 119 |
| 2022 5 | 98 | 36 | 134 |
| 2022 4 | 46 | 31 | 77 |
| 2022 3 | 42 | 42 | 84 |
| 2022 2 | 40 | 20 | 60 |
| 2021 1 | 83 | 42 | 125 |
| 2021 12 | 40 | 34 | 74 |
| 2021 11 | 53 | 34 | 87 |
| 2021 10 | 64 | 59 | 123 |
| 2021 9 | 78 | 42 | 120 |
| 2021 8 | 65 | 31 | 96 |
| 2021 7 | 72 | 36 | 108 |
| 2021 6 | 84 | 52 | 136 |
| 2021 5 | 65 | 48 | 113 |
| 2021 4 | 163 | 88 | 251 |
| 2021 3 | 118 | 28 | 146 |
| 2021 2 | 110 | 34 | 144 |
| 2020 1 | 85 | 42 | 127 |
| 2020 12 | 75 | 25 | 100 |
| 2020 11 | 49 | 18 | 67 |
| 2020 10 | 82 | 31 | 113 |
| 2020 9 | 53 | 26 | 79 |
| 2020 8 | 53 | 23 | 76 |
| 2020 7 | 54 | 21 | 75 |
| 2020 6 | 61 | 32 | 93 |
| 2020 5 | 63 | 25 | 88 |
| 2020 4 | 55 | 22 | 77 |
| 2020 3 | 42 | 13 | 55 |
| 2020 2 | 6 | 2 | 8 |
| 2019 12 | 1 | 2 | 3 |
| 2019 11 | 3 | 1 | 4 |
| 2019 8 | 7 | 0 | 7 |
| 2019 6 | 0 | 0 | 0 |
| 2019 5 | 1 | 0 | 1 |
| 2019 4 | 1 | 3 | 4 |
| 2019 3 | 2 | 0 | 2 |
| 2019 2 | 1 | 0 | 1 |
| 2019 1 | 1 | 0 | 1 |
| 2018 12 | 4 | 0 | 4 |
| 2018 11 | 1 | 0 | 1 |
| 2018 10 | 5 | 2 | 7 |
| 2018 9 | 4 | 0 | 4 |
| 2018 7 | 1 | 0 | 1 |
| 2018 5 | 2 | 0 | 2 |
| 2018 2 | 10 | 1 | 11 |
| 2018 1 | 5 | 0 | 5 |
| 2017 12 | 11 | 1 | 12 |
| 2017 11 | 8 | 0 | 8 |
| 2017 10 | 4 | 0 | 4 |
| 2017 9 | 10 | 1 | 11 |
| 2017 8 | 9 | 0 | 9 |
| 2017 7 | 5 | 0 | 5 |
| 2017 6 | 18 | 0 | 18 |
| 2017 5 | 7 | 1 | 8 |
| 2017 4 | 6 | 0 | 6 |
| 2017 3 | 4 | 0 | 4 |
| 2017 2 | 11 | 1 | 12 |
| 2016 1 | 8 | 0 | 8 |
| 2016 12 | 11 | 7 | 18 |
| 2016 11 | 44 | 20 | 64 |
| 2016 10 | 0 | 1 | 1 |
| 2016 9 | 0 | 1 | 1 |
Mostrar todo
